by Alexis DUPORT | 30 Nov, 2009 | Gènéthique informs you
Authorisation of the FDA At the beginning of 2009 the Food and Drug Administration (FDA) has granted authorization to Geron Corporation, the leader company in research on embryonic stem cells, for a clinical trial on patients withlesions of spinal...
by Alexis DUPORT | 30 Nov, 2009 | Gènéthique informs you
Euthanasia rejected by deputies At the end of November 2009, deputies have rejected with 326 votes against 202, the bill supported by the socialist Manuel Valls on euthanasia. He wanted to establish a “medical assistance to die in dignity”. Concretely, the text...
by Alexis DUPORT | 31 Oct, 2009 | Gènéthique informs you
Antinatalism (reduction of birth rate) for ecological reasons? If the idea is not original, it comes back in force today, to the point of inspiring reports from important international organisations. This way the 2009 report of the United Nations Population Fund...
by Alexis DUPORT | 31 Oct, 2009 | Gènéthique informs you
News about Down syndrome show the contradictions of our society regarding Down syndrome people: “We are all disconcerted by this handicap. No one can deny the humanity of these children. And yet…The French society has difficulties to face it”, the newspaper...
by Alexis DUPORT | 30 Sep, 2009 | Gènéthique informs you
In a report published on 6th May 2009, the Council of State advocates a possible review on the legislation which governs the saviour child procedure or “double PGD”: “The questions raised by the ‘double PGD’ and the fact that it was not so much used...
by Alexis DUPORT | 30 Sep, 2009 | Gènéthique informs you
A new therapeutic perspective maybe opens for the patients with Parkinson’s disease. A gene triple therapy, established by teams of Bachir Jaraya and Stéphane Palfi, neurosurgeons at the Hospital Henri Mondor and CEA/Inserm researchers, allowed to 18 macaques with...
